Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules

Clinical Endocrinology

Volumn 50, Issue 2, 1999, Pages 197-202

  Nygaard, Birte ^b   Hegedüs, Laszlo ^a   Nielsen, Kamilla Gerhard ^c   Ulriksen, Peter ^c   Hansen, Jens Mølholm ^c  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; EUTHYROIDISM; FEMALE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; THYROID FUNCTION; THYROID NODULE; THYROTOXICOSIS;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THYROID GLAND; THYROID NODULE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033048897     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00635.x     Document Type: Article

References (26)

1. Bennedbæk, F.N., Karstrup, S. & Hegedüs, L. (1997) Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. European Journal of Endocrinology, 136, 240-250.
2. Berglund, J., Christensen, S.B., Dymling, J.F. & Hallengren, B. (1991) The incidence of recurrence and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with hyperthyroidism in Malmö during the period 1970-74. Journal of Internal Medicine, 229, 435-442.
3. Bliddal, H., Hansen, J.M., Rogowski, P., Johansen, K., Friis, T. & Siersbæk-Nielsen, K. (1982) 131I treatment of diffuse and nodular toxic goitre with or without antithyroid agents. Acta Endocrinologica (Copenhagen), 99, 517-521.
4. Clere, J., Dagousset, F., Izembart, M., Jais, J.P., Heshmati, H.M., Alcais, A., Chevalier, A., Léger, A.F. & Barritault, L. (1995) Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity. Journal of Nuclear Medicine, 36, 217-223.
5. Farrari, C., Reschini, E. & Paracchi, A. (1996). Treatment of the autonomous thyroid nodule: a review. European Journal of Endocrinology, 135, 383-390.
6. 131I) therapy for autonomous hyperfunctioning thyroid nodule evaluated by means of life-table method. Journal of Nuclear Medicine and Science, 24, 85-91.
7. 131I. New England Journal of Medicine, 309, 1473-1476.
8. Hancock, L.D., Tuttle, M., LeMar, H., Bauman, J. & Patience, T. (1997) The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clinical Endocrinology. 47, 425-430.
9. Hegedüs, L., Perrild, H., Poulsen, L.R., Andersen, J.R., Holm, B., Schnohr, P., Jensen, G. & Hansen, J.M. (1983) Determination of thyroid volume by ultrasound and its relationship to body weight, age and sex in normal subjects. Journal of Clinical Endocrinology and Metabolism, 56, 260-263.
10. Hegedüs, L. & Hansen, J.M. (1986) Radioactive iodine for thyrotoxicosis. Lancet, 2, 339-340, 876.
11. 131I-therapy of solitary autonomous thyroid nodules: effect on thyroid size and early hypothyroidism. Acta Endocrinologica (Copenhagen), 113, 226-232.
12. Hegedüs, L., Hansen, B.M., Knudsen, N. & Hansen, J.M. (1988) Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. British Medical Journal, 297, 661-662.
13. Hegedüs, L. & Bennedbæk, F.N. (1997) Radioiodine for non-toxic diffuse goitre, Lancet, 350, 409-410.
14. Huysmans, D.A.K.C., Cortens, F.H.M. & Kloppenborg, P.W.C. (1991) Long-term follow-up in toxic solitary' autonomous thyroid nodules treated with radioactive iodine. Journal of Nuclear Medicine, 32, 27-30.
15. 131I treatment of hyperthyroidism. Thyroidology, Clinical and Experimental, 9, 55-59.
16. Jarløv, A.E., Hegedüs, L., Gjørup, T. & Hansen, J.E.M. (1991) Accuracy of the clinical assessment of thyroid size. Danish Medical Bulletin, 38, 87-89.
17. Kung, A.W.C., Choi, P., Lam, K.S.L., Pun, K.K., Wang, C. & Yeung, R.T.T. (1990) Discriminant factors affecting early outcome of radioiodine treatment for Graves' disease. Clinical Radiology. 42, 52-54.
18. Laurberg, P., Pedersen, K.M., Vestergaard, H. & Sigurdsson, G. (1991) High incidence of multinodular toxic goitre in the elderly population in a low intake iodine area vs. high incidence of Graves' disease in the young in a high iodine area: comparative surveys of hyperthyroidism epidemiology in East-Jutland, Denmark and Iceland. Journal of Internal Medicine, 229, 415-420.
19. Mariotti, S., Martino, E., Francesconi, M., Ceccarelli, C., Grasso, L., Lippi, F., Baschieri, L. & Pinchera, A. (1986) Serum thyroid autoantibodies as a risk factor for development of hypothyroidism after radioactive iodine therapy for single hot nodule. Acta Endocrinologica (Copenhagen), 113, 500-507.
20. 131I-treatment for solitary autonomous nodules. Thyroid, 8, 223-227.
21. 131I treatment of diffuse non-toxic goitre. Clinical Endocrinology. 46, 493-496.
22. 131I therapy on thyroid volume and incidence of hypothyroidism in Graves' disease. Journal of Internal Medicine, 238, 491-497.
23. Nygaard, B., Hegedüs, L., Gervil, M., Hjalgrim, H., Søe-Jensen, P. & Hansen, J.M. (1993) Radioiodine treatment of multinodular non-toxic goitre. British Medical Journal, 307, 828-832.
24. O'Brien, T., Gharib, H., Suman, V.J. & van Heerden, J.A. (1992) Treatment of toxic solitary thyroid nodules: surgery versus radioactive iodine. Surgery, 112, 1166-1170.
25. Rateliffe, G.E., Cooke, S., Fogelman, I. & Maisey, M.N. (1986) Radioiodine treatment of solitary functioning thyroid nodules. British Medical Journal, 59, 385-387.
26. 131, with low prevalence of hypothyroidism. Annals of Internal Medicine, 101, 488-490.